Nachrichten zur Abbvie Inc. Aktie

AbbVie Beats on Q2 Earnings & Sales, Stock Up on Raised 25 EPS View

ABBV tops Q2 forecasts and lifts 2025 EPS outlook as Rinvoq and Skyrizi drive growth amid Humiras decline.…

AbbVie Quartalszahlen Q2: Umsatz und Gewinn über Erwartungen

Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt in…

AbbVie: Bockstarke Zahlen – Dividenden-Aktie mit Kaufsignal

Der US-amerikanische Pharma-Konzern AbbVie hat hervorragende Zahlen zum zweiten Quartal vorgelegt und die Gewinnprognose nach oben geschraubt. Es zeichnet sich…

AbbVie: Bockstarke Zahlen – Dividenden-Aktie mit Kaufsignal

Der US-amerikanische Pharma-Konzern AbbVie hat hervorragende Zahlen zum zweiten Quartal vorgelegt und die Gewinnprognose nach oben geschraubt. Es zeichnet sich…

AbbVie lifts annual profit forecast on strong demand for newer immunology drugs

AbbVie raised its 2025 profit forecast on Thursday, after beating Wall Street estimates for second-quarter results on strong sales of…

AbbVie in talks to buy Gilgamesh Pharma for $1 bln- Bloomberg By Investing.com

AbbVie in talks to buy Gilgamesh Pharma for $1 bln- Bloomberg…

AbbVie in talks to acquire Gilgamesh Pharmaceuticals By Reuters

AbbVie in talks to acquire Gilgamesh Pharmaceuticals…

Trumps pharmaceutical tariffs could affect some drugmakers more than others

AbbVie, Bristol Myers Squibb and Eli Lilly appear "relatively well-positioned," while Novartis and Roche look more at risk, TD Cowen…

The Best High-Yield Dividend ETF to Own for the Next 10 Years

Key PointsCompanies must pass key tests to be included in the Schwab U.S. Dividend Equity ETF.This fund has averaged a…

AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release

AbbVie (ABBV) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its upcoming…

AbbVie (ABBV) Outperforms Broader Market: What You Need to Know

AbbVie (ABBV) reached $187.12 at the closing of the latest trading day, reflecting a +1.23% change compared to its last…

All It Takes Is $2,000 Invested in Each of These High Dividend Stocks to Help Generate Over $280 in Passive Income Per Year

Key PointsIncome-focused investors seeking reliable dividends and a stable company can consider investing in telecommunications giant Verizon. AT&T’s disciplined financial…

AbbVie (ABBV) Surpasses Market Returns: Some Facts Worth Knowing

The latest trading day saw AbbVie (ABBV) settling at $190.58, representing a +2.25% change from its previous close.…

3 Dividend Growth Stocks to Buy and Hold

Key PointsAbbott Laboratories is a dividend growth machine thats known for consistency.AbbVies dividend has more than quadrupled since 2013.Eli Lilly…

AbbVie: Neuer Deal – indische Pharma-Aktie fliegt

Der US-amerikanische Pharma-Riese AbbVie baut sein Entwicklungsportfolio im Bereich der Onkologie weiter aus. Die Gesellschaft sichert sich die Rechte an…

AbbVie: Neuer Deal – indische Pharma-Aktie fliegt

Der US-amerikanische Pharma-Riese AbbVie baut sein Entwicklungsportfolio im Bereich der Onkologie weiter aus. Die Gesellschaft sichert sich die Rechte an…

ABBV or BMY: Which Biopharma Giant Has Better Prospects for Now?

AbbVie edges ahead of Bristol Myers with strong Skyrizi and Rinvoq growth, offsetting Humira declines and portfolio headwinds.…

AbbVie (ABBV) Laps the Stock Market: Heres Why

AbbVie (ABBV) closed the most recent trading day at $195, moving +2.3% from the previous trading session.…

AbbVie stock jumps after $700 million licensing deal with IGI Therapeutics By Investing.com

AbbVie stock jumps after $700 million licensing deal with IGI Therapeutics…

LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million

Key PointsLVM Capital Management shed 16,096 shares valued at $2.58 million.LVM now holds 40,603 ICON shares valued at $5.91 million.ICON…

3 No-Brainer Stocks to Buy in July

Key PointsAbbVie offers something for every investor.Eli Lilly could be overdue for a big rally.Vertex Pharmaceuticals is in a new…

2 Dividend Stocks to Buy for Decades of Passive Income

Key PointsHealthcare giants AbbVie and Abbott Laboratories are both Dividend Kings.They should maintain their dividend growth habits for a long…

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

Key PointsAbbVie is a Dividend King with solid growth prospects.Enbridge is a leading pipeline operator and natural gas utility with…

AbbVie: Q2 Earnings Warning Reflects Poor R&D, But Its Not A Red Flag

…

Is It Worth Investing in AbbVie (ABBV) Based on Wall Streets Bullish Views?

According to the average brokerage recommendation (ABR), one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after…

Can Buying the Vanguard S&P 500 ETF Make You a Millionaire?

Buying an exchange-traded fund (ETF) that tracks an index like the S&P 500 can be a great way to build…

The Zacks Analyst Blog Highlights Alphabet, AbbVie and The Walt Disney

GOOGL, ABBV, and DIS face rising costs and competition, but strong cloud, immunology, and parks growth continue to fuel optimism.…

HDV Is a Popular Dividend ETF for Passive Income. But Is It the Best?

Artificial intelligence (AI), big tech, and cryptocurrencies all have their fans among investors, and with good reason. All can add…

Abbvie confirms $2.1bn Capstan swoop

Abbvie Inc (NYSE:ABBV) has agreed to acquire Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its pipeline…

Abbvie confirms $2.1B Capstan swoop

Abbvie Inc (NYSE:ABBV) has agreed to acquire Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its pipeline…

DGRO Is a Popular Dividend ETF for Passive Income, but Is It the Best?

Many, if not most, of us would do well to include a bunch of dividend payers in our portfolio. Naturally,…

3 Dividend Stocks to Double Up on Right Now

Buy, sell, or hold? Thats the question investors must continually ask about each stock in their portfolio. The correct answer might…

Got $500? 2 Healthcare Stocks to Buy and Hold Forever

I dont know if well be riding in personal aircraft 20 years from now, like George Jetson did in the…

AbbVie (ABBV) Stock Dips While Market Gains: Key Facts

AbbVie (ABBV) closed at $182.31 in the latest trading session, marking a -2.4% move from the prior day.…

5 Vanguard ETFs to Buy With $1,000 and Hold Forever

Investing in exchange-traded funds (ETFs) is a great way for both new and experienced investors to gain market exposure, and…

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock…

Heres Why AbbVie (ABBV) Fell More Than Broader Market

In the most recent trading session, AbbVie (ABBV) closed at $185.48, indicating a -2.82% shift from the previous trading day.…

Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trumps plan

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating billions…

Pfizer, AbbVie und Co unter Druck: Trump mit dem nächsten Hammer?

US-Präsident Donald Trump will der Pharma-Industrie weiter an den Kragen gehen. Laut Kreisen möchte der Republikaner die Pharmawerbung in den…

Pfizer, AbbVie und Co unter Druck: Trump mit dem nächsten Hammer?

US-Präsident Donald Trump will der Pharma-Industrie weiter an den Kragen gehen. Laut Kreisen möchte der Republikaner die Pharmawerbung in den…

AbbVies Venclexta Misses Goal in Myelodysplastic Syndromes Study

Venclexta fails to meet survival goals in ABBVs phase III MDS study, marking another clinical setback for the cancer drug.…

AbbVies Diversification Strategy Cushions Venetoclax MDS Blow

…

AbbVie fails in late-stage trial for Roche-partnered blood cancer therapy venetoclax

…

5 Large Drug Stocks That Are Poised to Ride on Sector Recovery

In the Large-Cap Pharmaceuticals industry, AbbVie, Novartis, Pfizer, Sanofi and Bayer are worth retaining amid macro pressure and rising innovation.…

2 High-Yielding ETFs That Can Generate Dividend Income for Your Portfolio for Decades

Investing in dividend stocks is a great way to generate a steady stream of recurring income for your portfolio. But…

AbbVie (ABBV) Gains As Market Dips: What You Should Know

The latest trading day saw AbbVie (ABBV) settling at $191.50, representing a +1.06% change from its previous close.…

AbbVie Inc. (ABBV) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript

…

AbbVie at Goldman Sachs Conference: Strategic Growth and Innovation By Investing.com

AbbVie at Goldman Sachs Conference: Strategic Growth and Innovation…

3 Stocks With Mouthwatering Dividends You Can Buy Right Now

How would you like to get paid every quarter (and sometimes every month) to own a stock? Thats exactly what…

AbbVie (ABBV) Increases Despite Market Slip: Heres What You Need to Know

The latest trading day saw AbbVie (ABBV) settling at $187.66, representing a +0.17% change from its previous close.…